Vitamin D deficiency may reduce efficacy of HIV treatment: study
The findings were published in the journal Clinical Nutrition
Washington: Low levels of vitamin D may reduce the effectiveness of HIV treatment in adults by limiting their immune recovery, a new study has found.
Those with human immunodeficiency virus - commonly known as HIV - often struggle with declining health because their immune systems can not effectively respond to common pathogens.
Their immune statuses, usually measured by CD4+T cells, normally improve when given HIV treatment.
"Because of the immune-destroying effects of HIV, infection usually results in relatively quick death without treatment," said study co-author Amara Ezeamama, an assistant professor of epidemiology and biostatistics in the College of Public Health at the University of Georgia in US. "The magic of antiretroviral therapy, the name for drugs to treat HIV, lies in its ability to restore immune function," Ezeamama said.
"Our goal was to understand whether vitamin D deficiency limits the amount of immune recovery benefit for persons on HIV treatment," she said.
Ezeamama conducted an 18-month longitudinal study in which the immune status of 398 HIV-positive adults was measured at 0, 3, 6, 12 and 18 months.
The researchers, through observation, related the rise in immune function to whether or not individuals had adequate levels of vitamin D.
Specifically, Ezeamama found that vitamin D helped the adults' CD4+T cells recover more quickly. CD4+T cells are a type of T cell that helps the immune system fight off pathogens.
For HIV-positive adults, CD4+T cells are critical because of their weakened immune systems. Ezeamama found that participants with sufficient levels of vitamin D recovered more of their immune function on average 65 CD4+T cells more than those with vitamin D deficiency. The benefit of vitamin D sufficiency seemed greater for younger and underweight HIV-positive adults.
"HIV destroys the capacity of the body to mount effective response to pathogens. Given different vitamin D levels, HIV-positive adults recovered at different rates. We found a relationship between vitamin D and CD4+T cells," she said.
During the study, the participants were observed while on highly active antiretroviral therapy, or HAART, which normally consists of three or more drugs and is currently the most common - and most effective - treatment for HIV-positive adults. Those on HAART take it daily.
"It's a cocktail of several medicines that controls the virus. In addition to HAART, ensuring vitamin D sufficiency may also be helpful in restoring immune function," Ezeamama said.
"As researchers, we want to know what we can do to help. Vitamin D is relatively cheap. If we intervene with it, it could give individual HIV-infected persons a modest immune recovery bump that will likely translate to big public health impact," she added.
The findings were published in the journal Clinical Nutrition.